CEACAM5 and colorectal carcinoma: Murine (CEA)-specific monoclonal antibodies were successfully tested in animals for their capacity to accurately localize tumors formed by human colorectal carcinoma cell lines with various levels of CEA expression and, as a result, their use is foreseen in radioimmunoguided surgery (RIGS) [7].